Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3858701
Reference Type
Journal Article
Title
Inhibition of long-chain acyl-CoA synthetase by the peroxisome proliferator perfluorodecanoic acid in rat hepatocytes
Author(s)
Vanden Heuvel, JP; Kuslikis, BI; Shrago, E; Peterson, RE
Year
1991
Is Peer Reviewed?
Yes
Journal
Biochemical Pharmacology
ISSN:
0006-2952
EISSN:
1873-2968
Volume
42
Issue
2
Page Numbers
295-302
Language
English
PMID
1859447
DOI
10.1016/0006-2952(91)90716-I
Web of Science Id
WOS:A1991FY08200014
URL
https://search.proquest.com/docview/16322965?accountid=171501
Exit
Abstract
Perfluorodecanoic acid (PFDA) is a potent peroxisome proliferator and is known to affect hepatic lipid metabolism in rats. The effects of PFDA on fatty acid utilization were examined in isolated rat hepatocyte suspensions and in rat liver mitochondria and microsomes. PFDA inhibited the oxidation of palmitic acid but not octanoic or pyruvic acids when hepatocytes were incubated with 1 mM PFDA. At this PFDA concentration the esterification of palmitic acid into triacylglycerols was also reduced. The activity of long-chain acyl-CoA synthetase (ACS), an enzyme essential for both oxidation and esterification of fatty acids, was reduced in hepatocytes incubated with 1 mM PFDA. Carnitine palmitoyltransferase (CPT), an important enzyme for the oxidation of long-chain fatty acids, was not altered in hepatocytes incubated with this PFDA concentration. In rat liver mitochondria, palmitate oxidation and ACS activity were reduced significantly (P less than 0.01) at a PFDA concentration that had no effect on CPT activity. The inhibition of ACS by PFDA was similar in liver mitochondria and microsome preparations. In mitochondria incubated with PFDA, the inhibition of ACS appears to be noncompetitive for the substrates palmitic acid and CoA. However, the ACS inhibition by PFDA appeared to be competitive for the ATP binding site of the enzyme. Several chain length perfluorinated fatty acids were examined for their ability to inhibit mitochondrial ACS. Short-chain perfluorinated fatty acids (perfluoroproprionic and -butyric acid) did not inhibit ACS activity. However, medium-chain perfluorinated acids (perfluorooctanoic, -ananoic and -decanoic acid) were found to be potent inhibitors of ACS in isolated mitochondria. Whether ACS inhibition is causally related to PFDA-induced peroxisome proliferation and altered lipid metabolism seen in vivo is yet to be determined.
Keywords
fatty-acid synthase; hepatocytes; inhibition; perfluorodecanoic acid; Biochemistry Abstracts 3: Amino Acids, Peptides & Proteins (till 1993); Microbiology Abstracts B: Bacteriology
Tags
PFAS
•
Additional PFAS (formerly XAgency)
Literature Search November 2019
Other Sources
TEDX
Screened Studies
Excluded
Exclude (TIAB)
•
Expanded PFAS SEM (formerly PFAS 430)
Litsearch: September 2019
Other Sources
PFAS TOX Database
Screened Studies
Excluded
Exclude (TIAB)
•
^Per- and Polyfluoroalkyl Substances (PFAS)
PFDA (335-76-2)
Literature Search
Pubmed
WOS
Toxline
•
PFAS 150
Literature Search August 2019
PubMed
Web of Science
Other sources
PFAS TOX Database
Not prioritized for screening
Perfluorodecanoic acid
•
PFAS Universe
Data Source
Web of Science
Pubmed
Perfluorodecanoate
Perfluorodecanoic acid
•
PFBA
Scopus: April 2021
June 2022 Pelch Database
•
PFDA
Literature Search
Pubmed
Toxline
WOS
Other
Published PFAS SEMs
Scopus: April 2021
Screening Results
In vitro/ex vivo/in silico
Other mechanistic studies
Title and Abstract Screening
Full Text Screening
Tagged as Supplemental
Mechanistic or MOA
June 2022 Pelch Database
Literature Searches (through April 2023 update and post-public comment/peer review)
Title & Abstract Screening
Full Text Screening
Tagged as Supplemental
In vitro and in silico models
•
PFNA
June 2022 Pelch Database
•
Yale PFAS Liver study
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity